|
BARD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.939200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.366100E-02 |
| Normal-vs-Stage2 |
7.022400E-04 |
| Normal-vs-Stage3 |
4.304800E-03 |
| Normal-vs-Stage4 |
1.604070E-02 |
| Stage1-vs-Stage2 |
5.108500E-02 |
| Stage1-vs-Stage3 |
2.602600E-01 |
| Stage1-vs-Stage4 |
4.292600E-01 |
| Stage2-vs-Stage3 |
2.655000E-01 |
| Stage2-vs-Stage4 |
3.054400E-01 |
| Stage3-vs-Stage4 |
9.582000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.019530E-02 |
| Normal-vs-AfricanAmerican |
1.451820E-01 |
| Normal-vs-Asian |
7.054200E-02 |
| Caucasian-vs-AfricanAmerican |
8.164800E-01 |
| Caucasian-vs-Asian |
9.580200E-01 |
| AfricanAmerican-vs-Asian |
8.746600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.717900E-02 |
| Normal-vs-Female |
4.921700E-03 |
| Male-vs-Female |
9.782600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.145020E-01 |
| Normal-vs-Age(41-60Yrs) |
8.824100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.256400E-03 |
| Normal-vs-Age(81-100Yrs) |
3.406300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.219600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.275700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.919240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.950400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.206200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.404800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.710160E-01 |
| Classical-VS-Follicular |
1.144230E-03 |
| Classical-VS-Other |
3.976800E-01 |
| Classical-VS-Normal |
6.552000E-02 |
| Tall-VS-Follicular |
3.101800E-01 |
| Tall-VS-Other |
7.266800E-01 |
| Tall-VS-Normal |
1.941530E-02 |
| Follicular-VS-Other |
8.086600E-01 |
| Follicular-VS-Normal |
8.24780000000525E-05 |
| Other-VS-Normal |
1.101040E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.082660E-03 |
| Normal-vs-N1 |
1.799650E-02 |
| N0-vs-N1 |
7.107400E-01 |
|
|
